| 000 | 01754 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518000400.0 | ||
| 264 | 0 | _c20190926 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-018-0789-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNicklas, André P | |
| 245 | 0 | 0 |
_aCalgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). _h[electronic resource] |
| 260 |
_bAdvances in therapy _c11 2018 |
||
| 300 |
_a2054-2068 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xanalysis |
| 650 | 0 | 4 |
_aCalgranulin A _xanalysis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xdiagnosis |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
| 700 | 1 | _aKramer, Mario W | |
| 700 | 1 | _aSerth, Jürgen | |
| 700 | 1 | _aHennenlotter, Jörg | |
| 700 | 1 | _aHupe, Marie C | |
| 700 | 1 | _aReimer, Daniel U | |
| 700 | 1 | _aStenzl, Arnulf | |
| 700 | 1 | _aMerseburger, Axel S | |
| 700 | 1 | _aKuczyk, Markus A | |
| 700 | 1 | _avon Klot, Christoph-Alexander J | |
| 773 | 0 |
_tAdvances in therapy _gvol. 35 _gno. 11 _gp. 2054-2068 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-018-0789-7 _zAvailable from publisher's website |
| 999 |
_c28852572 _d28852572 |
||